Leukocyte integrins and their ligand interactions

Immunologic Research

Volumn 45, Issue 2-3, 2009, Pages 195-208

  Hyun, Young Min ^a   Lefort, Craig T ^a   Kim, Minsoo ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Integrin; LFA 1; Mac 1; VLA 4

Indexed keywords

ABCIXIMAB; ALPHA4 INTEGRIN; BETA GLUCAN; BLOOD CLOTTING FACTOR 10; CD11B ANTIGEN; CD11B ANTIGEN ANTIBODY; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; EFALIZUMAB; FIBRINOGEN; FIBRONECTIN; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; INTERCELLULAR ADHESION MOLECULE 4; INTERCELLULAR ADHESION MOLECULE 5; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTAGONIST; NATALIZUMAB; NEUTROPHIL INHIBITORY FACTOR; RECOMBINANT NEUTROPHIL INHIBITORY FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ADJUVANT THERAPY; ALLERGY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; AUTOIMMUNE DISEASE; BLOOD VESSEL INJURY; BRAIN ISCHEMIA; CANCER IMMUNOTHERAPY; CELL ADHESION; CELL MIGRATION; CHRONIC INFLAMMATION; CLINICAL TRIAL; DRUG FATALITY; DRUG TARGETING; GRAFT FAILURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; ISCHEMIA; KIDNEY ALLOGRAFT REJECTION; LEUKOCYTE; MULTIPLE SCLEROSIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PSORIASIS; PSORIASIS VULGARIS; RESTENOSIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; AUTOIMMUNE DISEASES; CELL ADHESION; HUMANS; INTEGRINS; LEUKOCYTES; LIGANDS; MULTIPLE SCLEROSIS; PROTEIN BINDING;

EID: 72449156722     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8101-1     Document Type: Review

References (123)

1. TA Springer 1994 Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm Cell 76 301 14 7507411
2. M Shimaoka TA Springer 2003 Therapeutic antagonists and the conformational regulation of integrin structure and function Nat Rev Drug Discov 2 703 16 12951577
3. A Grakoui SK Bromley C Sumen MM Davis AS Shaw PM Allen ML Dustin 1999 The immunological synapse: a molecular machine controlling T cell activation Science 285 221 7 10398592
4. T Ulyanova GV Priestley ER Banerjee T Papayannopoulou 2007 Unique and redundant roles of alpha4 and beta2 integrins in kinetics of recruitment of lymphoid vs myeloid cell subsets to the inflamed peritoneum revealed by studies of genetically deficient mice Exp Hematol 35 1256 65 17553614
5. S Ghosh AA Chackerian CM Parker CM Ballantyne SM Behar 2006 The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection J Immunol 176 4914 22 16585587
6. SD Marlin TA Springer 1987 Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) Cell 51 813 9 3315233
7. AR de Fougerolles SA Stacker R Schwarting TA Springer 1991 Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1 J Exp Med 174 253 67 1676048
8. AR de Fougerolles X Qin TA Springer 1994 Characterization of the function of ICAM-3 and comparison to ICAM-1 and ICAM-2 in immune responses J Exp Med 179 619 29 7905020
9. L Tian P Kilgannon Y Yoshihara K Mori WM Gallatin O Carpen CG Gahmberg 2000 Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18 Eur J Immunol 30 810 8 10741396
10. E Ihanus L Uotila A Toivanen M Stefanidakis P Bailly JP Cartron CG Gahmberg 2003 Characterization of ICAM-4 binding to the I domains of the CD11a/CD18 and CD11b/CD18 leukocyte integrins Eur J Biochem 270 1710 23 12694184
11. G Ostermann KS Weber A Zernecke A Schroder C Weber 2002 JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes Nat Immunol 3 151 8 11812992
12. J Wang TA Springer 1998 Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses Immunol Rev 163 197 215 9700512
13. M Shimaoka T Xiao J-H Liu Y Yang Y Dong C-D Jun A McCormack R Zhang A Joachimiak J Takagi Wang J-h TA Springer 2003 Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation Cell 112 99 111 12526797
14. G van Seventer Y Shimizu K Horgan S Shaw 1990 The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells J Immunol 144 4579 86 1972160
15. G Mallinson PG Martin DJ Anstee MJ Tanner AH Merry D Tills HH Sonneborn 1986 Identification and partial characterization of the human erythrocyte membrane component(s) that express the antigens of the LW blood-group system Biochem J 234 649 52 2424433
16. K Katagiri M Hattori N Minato S Irie K Takatsu T Kinashi 2000 Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase Mol Cell Biol 20 1956 69 10688643
17. H Kawasaki GM Springett S Toki JJ Canales P Harlan JP Blumenstiel EJ Chen IA Bany N Mochizuki A Ashbacher M Matsuda DE Housman AM Graybiel 1998 A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia Proc Natl Acad Sci USA 95 13278 83 9789079
18. JR Crittenden W Bergmeier Y Zhang CL Piffath Y Liang DD Wagner DE Housman AM Graybiel 2004 CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation Nat Med 10 982 6 15334074
19. H Ghandour X Cullere A Alvarez FW Luscinskas TN Mayadas 2007 Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion Blood 110 3682 90 17702895
20. R Pasvolsky SW Feigelson SS Kilic AJ Simon G Tal-Lapidot V Grabovsky JR Crittenden N Amariglio M Safran AM Graybiel G Rechavi S Ben-Dor A Etzioni R Alon 2007 A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets J Exp Med 204 1571 82 17576779
21. T Kinashi K Katagiri 2004 Regulation of lymphocyte adhesion and migration by the small GTPase Rap1 and its effector molecule, RAPL Immunol Lett 93 1 5 15134891
22. K Katagiri M Imamura T Kinashi 2006 Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion Nat Immunol 7 919 28 16892067
23. K Katagiri A Maeda M Shimonaka T Kinashi 2003 RAPL, a novel Rap1-binding molecule, mediates Rap1-induced adhesion through spatial regulation of LFA-1 Nat Immunol 4 741 8 12845325
24. K Katagiri N Ohnishi K Kabashima T Iyoda N Takeda Y Shinkai K Inaba T Kinashi 2004 Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking Nat Immunol 5 1045 51 15361866
25. EM Lafuente AA van Puijenbroek M Krause CV Carman GJ Freeman A Berezovskaya E Constantine TA Springer FB Gertler VA Boussiotis 2004 RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion Dev Cell 7 585 95 15469846
26. DM Rose R Alon MH Ginsberg 2007 Integrin modulation and signaling in leukocyte adhesion and migration Immunol Rev 218 126 34 17624949
27. X Li X Bu B Lu H Avraham RA Flavell B Lim 2002 The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function Mol Cell Biol 22 1158 71 11809807
28. LK Cherry X Li P Schwab B Lim LB Klickstein 2004 RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes Nat Immunol 5 961 7 15300248
29. E Bianchi S Denti A Granata G Bossi J Geginat A Villa L Rogge R Pardi 2000 Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity Nature 404 617 21 10766246
30. W Kolanus W Nagel B Schiller L Zeitlmann S Godar H Stockinger B Seed 1996 αLβ2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule Cell 86 233 42 8706128
31. KS Weber C Weber G Ostermann H Dierks W Nagel W Kolanus 2001 Cytohesin-1 is a dynamic regulator of distinct LFA-1 functions in leukocyte arrest and transmigration triggered by chemokines Curr Biol 11 1969 74 11747824
32. A Mor ML Dustin MR Philips 2007 Small GTPases and LFA-1 reciprocally modulate adhesion and signaling Immunol Rev 218 114 25 17624948
33. OD Perez D Mitchell GC Jager S South C Murriel J McBride LA Herzenberg S Kinoshita GP Nolan 2003 Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1 Nat Immunol 4 1083 92 14528303
34. AR Bresnick 1999 Molecular mechanisms of nonmuscle myosin-II regulation Curr Opin Cell Biol 11 26 33 10047526
35. JS Berg BC Powell RE Cheney 2001 A millennial myosin census Mol Biol Cell 12 780 94 11294886
36. NA Morin PW Oakes YM Hyun D Lee EY Chin MR King TA Springer M Shimaoka JX Tang JS Reichner M Kim 2008 Nonmuscle myosin heavy chain IIAmediates integrin LFA-1 de-adhesion during T lymphocyte migration J Exp Med 205 195 205 18195072
37. M Lebwohl SK Tyring TK Hamilton D Toth S Glazer NH Tawfik P Walicke W Dummer X Wang MR Garovoy D Pariser 2003 A novel targeted T-cell modulator, efalizumab, for plaque psoriasis N Engl J Med 349 2004 13 14627785
38. DL Simmons 2005 Anti-adhesion therapies Curr Opin Pharmacol 5 398 404 15955735
39. GM Gauvreau AB Becker LP Boulet J Chakir RB Fick WL Greene KJ Killian PM O'Byrne JK Reid DW Cockcroft 2003 The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma J Allergy Clin Immunol 112 331 8 12897739
40. A Fischer W Friedrich A Fasth S Blanche F Le Deist D Girault F Veber J Vossen M Lopez C Griscelli, et al. 1991 Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for immunodeficiency/European Group for bone marrow transplantation report Blood 77 249 56 1985691
41. R Gonzalez-Amaro M Mittelbrunn F Sanchez-Madrid 2005 Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords? Immunology 116 289 96 16236118
42. B Le Mauff M Hourmant JP Rougier M Hirn J Dantal R Baatard D Cantarovich Y Jacques JP Soulillou 1991 Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation Transplantation 52 291 6 1871802
43. AM Stoppa D Maraninchi D Blaise P Viens M Hirn D Olive J Reiffers N Milpied MH Gaspard C Mawas 1991 Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host disease Transpl Int 4 3 7 2059297
44. JM Cantor MH Ginsberg DM Rose 2008 Integrin-associated proteins as potential therapeutic targets Immunol Rev 223 236 51 18613840
45. T Springer G Galfre DS Secher C Milstein 1979 Mac-1: a macrophage differentiation antigen identified by monoclonal antibody Eur J Immunol 9 301 6 89034
46. EF Plow L Zhang 1997 A MAC-1 attack: integrin functions directly challenged in knockout mice J Clin Invest 99 1145 6 9077518
47. HI McFarland SR Nahill JW Maciaszek RM Welsh 1992 CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection J Immunol 149 1326 33 1500720
48. TA Springer WS Thompson LJ Miller FC Schmalstieg DC Anderson 1984 Inherited deficiency of the Mac-1, LFA-1, p150, 95 glycoprotein family and its molecular basis J Exp Med 160 1901 18 6096477
49. LJ Miller DF Bainton N Borregaard TA Springer 1987 Stimulated mobilization of monocyte Mac-1 and p150, 95 adhesion proteins from an intracellular vesicular compartment to the cell surface J Clin Invest 80 535 44 3038962
50. RF Todd III MA Arnaout RE Rosin CA Crowley WA Peters BM Babior 1984 Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion J Clin Invest 74 1280 90 6480827
51. NB Vedder JM Harlan 1988 Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium J Clin Invest 81 676 82 3278004
52. MS Diamond TA Springer 1993 A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen J Cell Biol 120 545 56 7678422
53. PC Davey M Zuzel AS Kamiguti JA Hunt KA Aziz 2000 Activation-dependent proteolytic degradation of polymorphonuclear CD11b Br J Haematol 111 934 42 11122158
54. M Phillipson B Heit P Colarusso L Liu CM Ballantyne P Kubes 2006 Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade J Exp Med 203 2569 75 17116736
55. MS Diamond J Garcia-Aguilar JK Bickford AL Corbi TA Springer 1993 The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands J Cell Biol 120 1031 43 7679388
56. MS Diamond DE Staunton AR de Fougerolles SA Stacker J Garcia-Aguilar ML Hibbs TA Springer 1990 ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18) J Cell Biol 111 3129 39 1980124
57. CG Gahmberg 1997 Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules Curr Opin Cell Biol 9 643 50 9330867
58. DC Altieri R Bader PM Mannucci TS Edgington 1988 Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen J Cell Biol 107 1893 900 3053736
59. DI Beller TA Springer RD Schreiber 1982 Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor J Exp Med 156 1000 9 7153706
60. MR Ehlers 2000 CR3: a general purpose adhesion-recognition receptor essential for innate immunity Microbes Infect 2 289 94 10758405
61. MS Diamond DE Staunton SD Marlin TA Springer 1991 Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation Cell 65 961 71 1675157
62. M Lub Y van Kooyk CG Figdor 1996 Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54) J Leukoc Biol 59 648 55 8656049
63. ZM Ding JE Babensee SI Simon H Lu JL Perrard DC Bullard XY Dai SK Bromley ML Dustin ML Entman CW Smith CM Ballantyne 1999 Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration J Immunol 163 5029 38 10528208
64. VP Yakubenko VK Lishko SC Lam TP Ugarova 2002 A molecular basis for integrin alphaMbeta 2 ligand binding promiscuity J Biol Chem 277 48635 42 12377763
65. L Zhang EF Plow 1999 Amino acid sequences within the alpha subunit of integrin alpha M beta 2 (Mac-1) critical for specific recognition of C3bi Biochemistry 38 8064 71 10387051
66. KS Weber LB Klickstein C Weber 1999 Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains Mol Biol Cell 10 861 73 10198043
67. B Heit P Colarusso P Kubes 2005 Fundamentally different roles for LFA-1, Mac-1 and alpha4-integrin in neutrophil chemotaxis J Cell Sci 118 5205 20 16249234
68. SC Fagerholm TJ Hilden SM Nurmi CG Gahmberg 2005 Specific integrin alpha and beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms J Cell Biol 171 705 15 16301335
69. SC Fagerholm M Varis M Stefanidakis TJ Hilden CG Gahmberg 2006 alpha-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation Blood 108 3379 86 16857989
70. PJ Muchowski L Zhang ER Chang HR Soule EF Plow M Moyle 1994 Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18 J Biol Chem 269 26419 23 7929363
71. N Jiang M Chopp S Chahwala 1998 Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat Brain Res 788 25 34 9554941 (Pubitemid 28202140)
72. M Krams KR Lees W Hacke AP Grieve JM Orgogozo GA Ford 2003 Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279, 276 in acute ischemic stroke Stroke 34 2543 8 14563972
73. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigation. N Engl J Med. 1994;330:956-61.
74. JE Tcheng DE Kandzari CL Grines DA Cox MB Effron E Garcia JJ Griffin G Guagliumi T Stuckey M Turco M Fahy AJ Lansky R Mehran GW Stone 2003 Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial Circulation 108 1316 23 12939213
75. KM Anderson RM Califf GW Stone FJ Neumann G Montalescot DP Miller JJ Ferguson III JT Willerson HF Weisman EJ Topol 2001 Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention J Am Coll Cardiol 37 2059 65 11419888
76. T Inoue Y Sakai T Fujito K Hoshi T Hayashi K Takayanagi S Morooka 1998 Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis Thromb Haemost 79 54 8 9459323
77. A Pietersma M Kofflard LE de Wit T Stijnen JF Koster PW Serruys W Sluiter 1995 Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment Circulation 91 1320 5 7867168
78. JK Mickelson NM Lakkis G Villarreal-Levy BJ Hughes CW Smith 1996 Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 28 345 53 8800108
79. M Schwarz T Nordt C Bode K Peter 2002 The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2) Thromb Res 107 121 8 12431477
80. C Rogers ER Edelman DI Simon 1998 A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits Proc Natl Acad Sci USA 95 10134 9 9707613
81. GD Ross JA Cain BL Myones SL Newman PJ Lachmann 1987 Specificity of membrane complement receptor type three (CR3) for beta-glucans Complement 4 61 74 3040332
82. BP Thornton V Vetvicka M Pitman RC Goldman GD Ross 1996 Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18) J Immunol 156 1235 46 8558003
83. Y Xia V Vetvicka J Yan M Hanikyrova T Mayadas GD Ross 1999 The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells J Immunol 162 2281 90 9973505
84. F Hong RD Hansen J Yan DJ Allendorf JT Baran GR Ostroff GD Ross 2003 Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells Cancer Res 63 9023 31 14695221
85. J Yan V Vetvicka Y Xia A Coxon MC Carroll TN Mayadas GD Ross 1999 Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18) J Immunol 163 3045 52 10477568
86. SU Eisenhardt M Schwarz N Schallner J Soosairajah N Bassler D Huang C Bode K Peter 2007 Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents Blood 109 3521 8 17164347
87. RR Lobb ME Hemler 1994 The pathophysiologic role of alpha 4 integrins in vivo J Clin Invest 94 1722 8 7525645
88. BH Luo CV Carman TA Springer 2007 Structural basis of integrin regulation and signaling Annu Rev Immunol 25 619 47 17201681
89. A Puig-Kroger F Sanz-Rodriguez N Longo P Sanchez-Mateos L Botella J Teixido C Bernabeu AL Corbi 2000 Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells J Immunol 165 4338 45 11035069
90. GD Rosen JR Sanes R LaChance JM Cunningham J Roman DC Dean 1992 Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis Cell 69 1107 19 1377605
91. M Nieto M Gomez P Sanchez-Mateos E Fernandez M Marazuela R Sacedon A Varas R Gonzalez-Amaro AG Zapata ML Toribio F Sanchez-Madrid 1996 Expression of functionally active alpha 4 beta 1 integrin by thymic epithelial cells Clin Exp Immunol 106 170 8 8870716
92. F Prosper D Stroncek JB McCarthy CM Verfaillie 1998 Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function J Clin Invest 101 2456 67 9616217
93. JT Yang H Rayburn RO Hynes 1995 Cell adhesion events mediated by α4 integrins are essential in placental and cardiac development Development 121 549 60 7539359
94. SA Cunningham JM Rodriguez MP Arrate TM Tran TA Brock 2002 JAM2 interacts with alpha4beta1. Facilitation by JAM3 J Biol Chem 277 27589 92 12070135
95. K Ebnet A Suzuki S Ohno D Vestweber 2004 Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117 19 29 14657270
96. EC Butcher M Williams K Youngman L Rott M Briskin 1999 Lymphocyte trafficking and regional immunity Adv Immunol 72 209 53 10361577
97. R Alon PD Kassner MW Carr EB Finger ME Hemler TA Springer 1995 The integrin VLA-4 supports tethering and rolling in flow on VCAM-1 J Cell Biol 128 1243 53 7534768
98. C Berlin RF Bargatze UH von Andrian MC Szabo SR Hasslen RD Nelson EL Berg SL Erlandsen EC Butcher 1995 α4 integrins mediate lymphocyte attachment and rolling under physiologic flow Cell 80 413 22 7532110
99. TN Sims ML Dustin 2002 The immunological synapse: integrins take the stage Immunol Rev 186 100 17 12234366
100. M Mittelbrunn A Molina MM Escribese M Yanez-Mo E Escudero A Ursa R Tejedor F Mampaso F Sanchez-Madrid 2004 VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses Proc Natl Acad Sci USA 101 11058 63 15263094
101. KA Reedquist E Ross EA Koop RM Wolthuis FJ Zwartkruis Y van Kooyk M Salmon CD Buckley JL Bos 2000 The small GTPase, Rap1, mediates CD31-induced integrin adhesion J Cell Biol 148 1151 8 10725328
102. JL Bos J de Rooij KA Reedquist 2001 Rap1 signalling: adhering to new models Nat Rev Mol Cell Biol 2 369 77 11331911
103. LE Goldfinger J Han WB Kiosses AK Howe MH Ginsberg 2003 Spatial restriction of α4 integrin phosphorylation regulates lamellipodial stability and α4β1-dependent cell migration J Cell Biol 162 731 41 12913113
104. J Han DM Rose DG Woodside LE Goldfinger MH Ginsberg 2003 Integrin α4β1-dependent cell migration requires both phosphorylation and de-phosphorylation of the a4 cytoplasmic domain J Biol Chem 278 34845 53 12837751
105. TA Yednock C Cannon LC Fritz F Sanchez-Madrid L Steinman N Karin 1992 Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin Nature 356 63 6 1538783
106. S Ghosh E Goldin FH Gordon HA Malchow J Rask-Madsen P Rutgeerts P Vyhnalek Z Zadorova T Palmer S Donoghue 2003 Natalizumab for active Crohn's disease N Engl J Med 348 24 32 12510039
107. S Laberge H Rabb TB Issekutz JG Martin 1995 Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat Am J Respir Crit Care Med 151 822 9 7881677
108. H Offner S Subramanian SM Parker C Wang ME Afentoulis A Lewis AA Vandenbark PD Hurn 2006 Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages J Immunol 176 6523 31 16709809
109. A Laffon R Garcia-Vicuna A Humbria AA Postigo AL Corbi MO de Landazuri F Sanchez-Madrid 1991 Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis J Clin Invest 88 546 52 1830891
110. DK Podolsky 1991 Inflammatory bowel disease (1) N Engl J Med 325 928 37 1881418
111. DY Jackson 2002 α4 integrin antagonists Curr Pharm Des 8 1229 53 12052218
112. H Yusuf-Makagiansar ME Anderson TV Yakovleva JS Murray TJ Siahaan 2002 Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases Med Res Rev 22 146 67 11857637
113. C Berlin EL Berg MJ Briskin DP Andrew PJ Kilshaw B Holzmann IL Weissman A Hamann EC Butcher 1993 α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 Cell 74 185 95 7687523
114. ME Hemler MJ Elices C Parker Y Takada 1990 Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions Immunol Rev 114 45 65 2142475
115. L Steinman 2005 Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab Nat Rev Drug Discov 4 510 8 15931259
116. BK Kleinschmidt-DeMasters KL Tyler 2005 Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis N Engl J Med 353 369 74 15947079
117. A Langer-Gould SW Atlas AJ Green AW Bollen D Pelletier 2005 Progressive multifocal leukoencephalopathy in a patient treated with natalizumab N Engl J Med 353 375 81 15947078
118. G Van Assche M Van Ranst R Sciot B Dubois S Vermeire M Noman J Verbeeck K Geboes W Robberecht P Rutgeerts 2005 Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N Engl J Med 353 362 8 15947080
119. IJ Koralnik 2004 New insights into progressive multifocal leukoencephalopathy Curr Opin Neurol 17 365 70 15167073
120. TA Yousry EO Major C Ryschkewitsch G Fahle S Fischer J Hou B Curfman K Miszkiel N Mueller-Lenke E Sanchez F Barkhof EW Radue HR Jager DB Clifford 2006 Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy N Engl J Med 354 924 33 16510746
121. C Kummer MH Ginsberg 2006 New approaches to blockade of alpha4-integrins, proven therapeutic targets in chronic inflammation Biochem Pharmacol 72 1460 8 16870156
122. K Peter M Schwarz J Ylanne B Kohler M Moser T Nordt P Salbach W Kubler C Bode 1998 Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIbβ3) inhibitors Blood 92 3240 9 9787160
123. MJ Quinn EF Plow EJ Topol 2002 Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword? Circulation 106 379 85 12119257